Molecular Cytogenetics Market - Forecast to 2019

DUBLIN, Feb. 19, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/jzx9mp/molecular) has announced the addition of the "Molecular Cytogenetics Market - Forecast to 2019" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Molecular cytogenetics refers to the study of chromosomal structures with the use of molecular techniques. The technique provides a combination of both molecular and cytological approach to research and diagnosis. Molecular cytogenetics is considered as an indispensable tool for the diagnosis and research of numerous chromosomal aberrations. The technique is preferred over traditional chromosomal banding technique as traditional techniques provide low resolution level and may escape detection of copy number variations.

The breakthrough in the molecular cytogenetics technologies such FISH and aCGH are providing new dimensions to the areas of research and molecular diagnostics. These techniques are considered as invaluable tool for gene mapping, gene discovery and complex disease trait analysis. Molecular cytogenetics facilitates diagnosis and prognosis of diseases associated with hematological malignancies and solid tumors at molecular level. Likewise, alongwith diagnosis and prognosis of tumors, the technique is facilitating the practice of personalized medicines. The global molecular cytogenetics market was valued at USD 469.2 million in 2012 and is expected to grow at a CAGR of 23.4% from 2013 to 2019 to reach at an estimated value of USD 1.9 billion in 2019.

Currently, aCGH technique is gaining momentum as compared to FISH technique owing to higher resolution over other traditional banding techniques. Earlier, where cytogenetics field was limited to identification of chromosome structure, it has now expanded its horizons to assessment of structural and functional genetic anomalies. FISH characterized by its ability to interpret information at genome level currently, captures the lion's share of the molecular cytogenetics market. The technique has been utilized over the past decade for identification of various diseases and in suggesting accurate treatment options to the physicians. The technique is known for its accuracy, speed, sensitivity and high resolution over the traditional methods. Further, owing to its growing importance in laboratories the technique is backed by technological advancements such as improved fluroscence microscopes and digital imaging. Moreover, the technique is also supported by ongoing developments in the field of genomics and bioinformatics. FISH has become an essential tool for the validation of diseases and is being extensively used in laboratories and hospitals.

Key Topics Covered:

1 Preface

2 Executive Summary

3 Market Overview

4 Molecular Cytogenetics Market, by Technology

5 Molecular Cytogenetics Market, by Applications

6 Molecular Cytogenetics Market, by Geography

7 Recommendations

8 Company Profiles

Companies Mentioned:

• Abbott Laboratories
• Affymetrix, Inc
• Agilent Technologies, Inc
• Applied Spectral Imaging, Inc
• BI Biological Industries
• Bio-Rad Laboratories
• CytoTest Inc
• Cytognomix, Inc
• F Hoffmann-La Roche Ltd
• Illumina Inc
• LEICA BIOSYSTEMS
• Life Technologies Corporation
• Oxford Gene Technology
• PerkinElmer, Inc
• SciGene Corporation

For more information visit http://www.researchandmarkets.com/research/jzx9mp/molecular

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets